Violation Detail
Standard Cited: 19261153 G01
Inspection Nr: 1302977.015
Citation: 01002B
Citation Type: Other
Abatement Date: 07/09/2018 2
Initial Penalty: $0.00
Current Penalty: $0.00
Issuance Date: 06/05/2018
Nr Instances: 1
Nr Exposed: 7
Related Event Code (REC): R
Gravity:
Report ID: 0830500
Contest Date:
Final Order: 06/22/2018
Emphasis:
Substance: 9010
| Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
|---|---|---|---|---|---|---|
| Penalty | I: Informal Settlement | 06/22/2018 | $0.00 | 07/09/2018 | Other | |
| Penalty | Z: Issued | 06/05/2018 | $0.00 | 07/09/2018 | Serious |
Text For Citation: 01 Item/Group: 002B Hazard:
29 CFR 1926.1153(g)(1): Written exposure control plan. The employer shall establish and implement a written exposure control plan that contains at least the following elements: (i) A description of the tasks in the workplace that involve exposure to respirable crystalline silica; (ii) A description of the engineering controls, work practices, and respiratory protection used to limit employee exposure to respirable crystalline silica for each task; (iii) A description of the housekeeping measures used to limit employee exposure to respirable crystalline silica; and (iv) A description of the procedures used to restrict access to work areas, when necessary, to minimize the number of employees exposed to respirable crystalline silica and their level of exposure, including exposures generated by other employers or sole proprietors: (a) Grosvenor Masonry, Inc. at 13150 Quebec St., Thornton, CO 80602: On or before March 14, 2018, the employer did not provide a description of engineering controls, work practices, and respiratory protection used to limit employee exposure during mortar mixing. The employer was having workers mix mortar that contained crystalline silica. The work being conducted does not fall within Table 1 of 29 CFR 1926.1153. Employee exposure to respirable silica may result in an increased risk of developing serious silica-related diseases, including: Silicosis, lung cancer, chronic obstructive pulmonary disease (COPD), and kidney disease.
Translate